|
⚲
|
| Kristina Burow | |
|---|---|
| Firm | |
| Address | c/o Treeline Biosciences, Inc 500 Arsenal Street Watertown, Ma 02472 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Treeline Biosciences Inc | 021-556563 | Director | 200.1 M of 250.0 M |
||
| Metsera Inc | 021-529922 | Director | 215.0 M of 215.0 M |
||
| Treeline Biosciences Inc | 021-527039 | Director | 421.8 M of 421.8 M |
||
| Autobahn Therapeutics Inc | 021-520406 | Director | 100.8 M of 120.0 M |
||
| Mirador Therapeutics Inc | 021-509566 | Director | 333.0 M of 333.0 M |
||
| Mirador Therapeutics Inc | 021-509562 | Director | 80.0 M of 80.0 M |
||
| Boundless Bio Inc | 021-489721 | Director | 100.0 M of 100.0 M |
||
| Gossamer Bio Inc | 021-488995 | Director | 212.1 M of 212.1 M |
||
| Neumora Therapeutics Inc | 021-469477 | Director | 474.4 M of 474.4 M |
||
| Treeline Biosciences Inc | 021-461357 | Director | 261.3 M of 269.3 M |
||
| Gossamer Bio Inc | 021-452776 | Director | 120.0 M of 120.0 M |
||
| Boundless Bio Inc | 021-398232 | Director | 105.6 M of 105.6 M |
||
| Treeline Biosciences Inc | 021-397744 | Director | 211.7 M of 220.0 M |
||
| Vividion Therapeutics Inc | 021-390895 | Director | 135.0 M of 135.0 M |
||
| VIR Biotechnology Inc | 021-366580 | Executive Officer | 250.0 M of 250.0 M |
||
| VIR Biotechnology Inc | 021-366581 | Executive Officer | 32.4 M of 32.4 M |
||
| Boundless Bio Inc | 021-362715 | Director | 23.2 M of 52.5 M |
||
| Boragen Inc | 021-357103 | Executive Officer | 2.0 M of 2.0 M |
||
| Vividion Therapeutics Inc | 021-338900 | Director | 82.0 M of 82.0 M |
||
| Beam Therapeutics Inc | 021-335722 | Director | 135.0 M of 135.0 M |
||
| Boragen Inc | 021-333776 | Director | 3.0 M of 4.2 M |
||
| Beam Therapeutics Inc | 021-318897 | Director | 83.6 M of 83.6 M |
||
| Gossamer Bio Inc | 021-318226 | Director | 230.0 M of 230.0 M |
||
| Agbiome LLC | 021-317048 | Director | 65.0 M of 65.0 M |
||
| VIR Biotechnology Inc | 021-315844 | Director | 66.0 M | ||
| Metacrine Inc | 021-314940 | Director | 65.0 M of 65.0 M |
||
| Unity Biotechnology Inc | 021-308697 | Director | 55.0 M of 60.0 M |
||
| Gossamer Bio Inc | 021-303729 | Director | 70.5 M of 80.0 M |
||
| Gossamer Bio Inc | 021-303730 | Director | 70.5 M of 80.0 M |
||
| Scholar Rock Holding Corp | 021-302683 | Director | 47.0 M of 47.0 M |
||
| Metacrine Inc | 021-300578 | Director | 22.0 M of 22.0 M |
||
| Sienna Biopharmaceuticals Inc | 021-286730 | Director | 40.5 M of 40.5 M |
||
| Trelys Inc | 021-284608 | Director | 0.1 M of 0.1 M |
||
| Boragen Inc | 021-283118 | Director | 10.5 M of 10.5 M |
||
| Unity Biotechnology Inc | 021-275461 | Director | 151.2 M of 177.6 M |
||
| Scholar Rock LLC | 021-254433 | Director | 36.3 M of 40.0 M |
||
| Sienna Biopharmaceuticals Inc | 021-249771 | Director | 46.6 M of 50.0 M |
||
| Agbiome LLC | 021-246215 | Director | 34.5 M of 34.5 M |
||
| Lycera Corp | 021-242213 | Director | 29.9 M | ||
| Metacrine Inc | 021-237785 | Director | 37.8 M of 37.8 M |
||
| Lycera Corp | 021-214958 | Director | 4.0 M of 9.2 M |
||
| Cenexys Inc | 021-199666 | Director | 2.0 M of 6.1 M |
||
| Trelys Inc | 021-192949 | Director | 2.5 M of 2.5 M |
||
| Receptos Inc | 021-173676 | Director | 10.8 M of 50.0 M |
||
| Limerick Biopharma Inc | 021-152195 | Director | 9.9 M of 13.2 M |
||
| Kilimanjaro Energy Inc | 021-146058 | Director | 2.2 M of 2.2 M |
||
| Kilimanjaro Energy Inc | 021-146056 | Director | 0.9 M of 5.0 M |
||
| Arch Venture Management LLC | |||||
| Arch Venture Fund XIII LP | 021-504109 | Executive Officer | of 3.0 B |
3,309.7 | |
| Arch Venture Fund XII LP | 021-432243 | Executive Officer | 2.8 B of 2.9 B |
2,960.5 | |
| Arch Venture Fund Xi LP | 021-380955 | Executive Officer | 1.9 B of 1.9 B |
1,645.1 | |
| Arch Venture Fund X LP | 021-324494 | Executive Officer | 635.8 M of 675.0 M |
493.4 | |
| Arch Venture Fund X Overage LP | 021-324501 | Executive Officer | 635.8 M of 675.0 M |
530.4 | |
| Arch Venture Fund IX LP | 021-259517 | Executive Officer | 408.4 M of 550.0 M |
486.3 | |
| Arch Venture Fund IX Overage LP | 021-274831 | Executive Officer | of 450.0 M |
438.8 | |
| Arch Venture Fund VIII Overage LP | 021-235405 | Executive Officer | of 150.0 M |
156.0 | |
| Arch Venture Fund VIII LP | 021-216149 | Executive Officer | 400.5 M of 400.5 M |
384.3 | |